Table 2 Cohort characteristics of esophageal cancer patients
Clinicopathological characteristics | TYK2 protein expression level | ||
|---|---|---|---|
Low (n = 45) | High (n = 46) | P | |
Gender | |||
 Male | 29 (64.4%) | 39 (84.8%) | 0.113 |
 Female | 16 (35.6%) | 7 (15.2%) |  |
Age | |||
 ≤ 60 | 14 (31.1%) | 17 (37.0%) | 0.761 |
 > 60 | 31 (68.9%) | 29 (63.0%) |  |
Tumor size | |||
 ≤ 5 cm | 31 (68.9%) | 25 (54.3%) | 0.528 |
 > 5 cm | 14 (31.1%) | 21 (45.7%) |  |
Histological grade | |||
 Well/moderately | 30 (66.7%) | 37 (80.4%) | 0.355 |
 Poorly | 15 (33.3%) | 9 (19.6%) |  |
T classification | |||
 T1 | 4 (8.9%) | 2 (4.3%) | 0.543 |
 T2 | 7 (15.6%) | 5 (10.9%) |  |
 T3 | 32 (71.1%) | 38 (82.6%) |  |
 T4 | 2 (4.4%) | 1 (2.2%) |  |
N classification | |||
 N0 | 22 (48.9%) | 19 (41.3%) | 0.448 |
 N1 | 16 (35.6%) | 14 (30.4%) |  |
 N2 | 6 (13.3%) | 10 (21.8%) |  |
 N3 | 1 (2.2%) | 3 (6.5%) |  |
Clinical stage | |||
 1 | 5 (11.1%) | 2 (4.4%) | 0.033 |
 2 | 20 (44.5%) | 19 (41.3%) |  |
 3 | 18 (40.0%) | 21 (45.6%) |  |
 4 | 2 (4.4%) | 4 (8.7%) |  |